REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

osauhing TBD Pharmatech (Estonia)

Main Activities: Pharmaceutical and Medicine Manufacturing | Medicinal and Botanical Manufacturing
Secondary Activities: Petroleum and Petroleum Products Merchant Wholesalers (except Bulk Stations and Terminals)
Full name: osauhing TBD Pharmatech Profile Updated: March 24, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Russian Download a sample report

osauhing TBD Pharmatech is an enterprise in Estonia, with the main office in Tartu. The company operates in the Pharmaceutical and Medicine Manufacturing sector. The enterprise was incorporated on February 10, 2006. 58 (2023) employees currently work for osauhing TBD Pharmatech. The company’s latest financial report indicates a net sales revenue drop of 20.37% in 2023. During that time, osauhing TBD Pharmatech’s total assets decreased by 7.35%.

Headquarters
Tiigi tn 61b Tartu linn
Tartu; Tartu county; Postal Code: 50410

Contact Details: Purchase the osauhing TBD Pharmatech report to view the information.

Website: https://tbdpharmatech.com/

Basic Information
Total Employees:
Purchase the osauhing TBD Pharmatech report to view the information.
Registered Capital:
Purchase the osauhing TBD Pharmatech report to view the information.
Financial Auditors:
Purchase the osauhing TBD Pharmatech report to view the information.
Incorporation Date:
February 10, 2006
Key Executives
Purchase this report to view the information.
Member of Management Board
Purchase this report to view the information.
Member of Management Board
Ownership Details
Purchase this report to view the information.
70%
Purchase this report to view the information.
30%
Company Performance
Financial values in the chart are available after osauhing TBD Pharmatech report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
-20.37%▼
Total operating revenue
-20.37%▼
Operating profit (EBIT)
N/A
EBITDA
-99.52%▼
Net Profit (Loss) for the Period
N/A
Total assets
-7.35%▼
Total equity
-3.54%▼
Operating Profit Margin (ROS)
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Cash Ratio
0.52%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo